This grand event, spanning all academic fields of experimental medicine and in vitro diagnostics (IVD), as well as IVD industry upgrading and global market expansion, stands as a premier global exposition and academic conference covering the entire IVD industry chain. It involves over 1,300 manufacturers and attracts participation from tens of thousands of distributors, medical institutions, research institutes, and educational units, with total attendance exceeding 100,000. The event has established core matrices encompassing academic discussions, raw material circulation, global expansion strategies, primary healthcare, veterinary diagnostics, and AI technology applications.
Led by academicians, the "Clinical Needs Express" directly addresses research challenges, while the presence of the IFCC President lends strong support to the exhibition. The Digital Twin Innovation Competition accelerates the iteration of cutting-edge technologies, and the Primary Healthcare Forum outlines a roadmap for implementing tiered medical services. From experimental diagnostic technologies to exploring the billion-dollar blue ocean of veterinary medicine, and from capital matchmaking for listed companies to precise supply-demand matching through hundreds of corporate satellite meetings, every aspect exemplifies the collaborative development of production, academia, research, application, translation, and innovation—reshaping the value growth engine of the IVD industry.
This year's exhibition is divided into eight zones: instruments and reagents, general laboratory equipment, upstream raw materials, consumables, supply chain, components, veterinary diagnostics, and an international zone. Delegations from Canada, Germany, and South Korea, as well as industry associations, are participating in group exhibitions. Representatives from the embassies and consulates of the UK, Switzerland, and Canada, along with trade officials, are also attending.
In his opening speech, Vice Mayor Fang Yi stated that as the core engine of China's IVD industry development, Hangzhou has established an innovation ecosystem covering the entire industrial chain. Data shows that the city is home to over 200 IVD-related enterprises, including six listed companies and 17 near-unicorn companies. In 2023, the output value of Hangzhou’s biomedical industry exceeded 150 billion yuan, with the IVD sector contributing over 40% and maintaining a 20% high growth rate for five consecutive years. Leveraging strengths in molecular diagnostics and POCT equipment, Hangzhou’s products are exported to more than 80 countries, with annual exports exceeding 20 billion yuan.
Vice Mayor Fang emphasized that in Hangzhou, every sample can find an answer, and every technology can find a stage. The city remains committed to fostering a business-friendly environment with "sincerity in attracting talent" and "the ambition to pursue excellence," providing enterprises with comprehensive services spanning "R&D-production-certification-market launch," along with superior industrial policies and efficient government support.
Professor Song Haibo, Vice President of the National Health Industry Enterprise Management Association, President of the Medical Laboratory Industry Branch, and founder of CACLP, stated in his speech:
The Experimental Medicine In Vitro Diagnostics (IVD) Conference serves as a "probe": It explores and witnesses the development of China's IVD industry from weakness to strength, promotes the adoption of cutting-edge IVD technologies, and guides the healthy future direction of the IVD industry.
The Experimental Medicine IVD Conference acts as a "primer": It leads China's IVD industry forward with unwavering determination, drives the industry's international expansion from "In China, for China" to "In China, for the world," and fosters global collaboration and exchange in the IVD sector.
Together, we create brilliance. Let us harness the power of innovation to propel the IVD industry toward sustained growth. As we embark on a new journey of internationalization, we will contribute China's strength to the advancement of global experimental medicine!
In the future, the Organizing Committee of the Experimental Medicine · In Vitro Diagnostics (IVD) Expo aims to establish an "exhibition equals ecosystem integration" industry community—a truly beneficial platform for all segments of the industrial chain. The event will actively evolve its value proposition into a "technology hub + industry router + capital aggregator," transforming the traditional exhibition model into infrastructure that drives industry transformation.